ArticleFrontiers in neurology2025
The effect of vagal nerve stimulation treatment on autonomic nervous system in patients with refractory epilepsy.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vagal nerve stimulation (VNS) is a treatment that can be used in drug-resistant epilepsy (DRE) patients who are not suitable for resective surgery. Effects of VNS on the autonomic system are controversial. In our study, we examined SSR and R-R interval variability (RR-IV) to evaluate autonomic functions in patients with refractory epilepsy treated with and without VNS and healthy volunteers. Methods: Our study included 41 healthy volunteers without any disease or drug administration, 38 DRE patients without VNS, and 38 DRE patients with VNS. Electrophysiological tests of sympathetic skin response (SSR) and RR interval variability (RR-IV) analysis were performed. Results: While no statistically significant difference was observed between the SSR latencies and amplitudes of the DRE group with VNS and the DRE group without VNS, when the SSR latencies of the 4 extremities of the DRE groups with and without VNS and the control group were compared, it was observed that both groups had statistically significantly longer SSR latencies in all extremities compared to the control group. A statistically significant difference was observed between the DRE with VNS group and the control group and RR-IV was lower in the DRE with VNS group. Conclusion: In conclusion, our study is one of the rare studies investigating the effects of VNS on the sympathetic system in patients with refractory epilepsy. According to the SSR and RR-IV results in our study, there was no evidence that VNS caused sympathetic dysfunction. However, VNS may cause a shift in cardiac sympathovagal balance toward sympathetic dominance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.